A carregar...
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
Despite the availability of a lot of effective disease-modifying drugs, multiple sclerosis (MS) (in particular the progressive forms) still represents an important unmet medical need, because of issues in terms of effectiveness, duration of response, safety, and patient compliance. An increasing bod...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8290177/ https://ncbi.nlm.nih.gov/pubmed/34295328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.661882 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|